Effect of Biophytum sensitivum on cell-mediated immune response in mice

Immunopharmacology and Immunotoxicology

Volumn 29, Issue 3-4, 2007, Pages 337-350

  Guruvayoorappan, C ^a   Kuttan, G ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Biophytum Sensitivum; Cell Mediated Immunity; Mitogenic Proliferation

Indexed keywords

BIOPHYTUM SENSITIVUM EXTRACT; CONCANAVALIN A; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; PLANT EXTRACT; POKEWEED MITOGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BAGG ALBINO MOUSE; BIOPHYTUM SENSITIVUM; BONE MARROW CELL; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; MEDICINAL PLANT; MITOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; THYMOCYTE;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BONE MARROW CELLS; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CELL PROLIFERATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY, CELLULAR; INDICATORS AND REAGENTS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MITOGENS; PLANT EXTRACTS; PLANTS, MEDICINAL; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; BIOPHYTUM; BIOPHYTUM SENSITIVUM; MUS;

EID: 37149020747     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970701606163     Document Type: Article

References (31)

1. Patwardhan, B. Ayurveda and future drug development. J. Altr. Comp. Med. 1992, 10(12), 9-10.
2. Steven, A.; Rosenberg, D.; Logo, L.; Lotze, M.T. In: Devia Jr. V.T., Hellman, S.; Rosenberg, S.A., Ed. Principles and Application of Biologic Therapy 1985, pp 301-302.
3. Whiteside, T.L.; Herberman, R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 1995, 7, 704-710.
4. Mellstedt, H. Monoclonal antibodies in human cancer. Drugs Today 2003, 39 (Suppl.), C1-C16.
5. Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br. J. Cancer. 2002, 87: 21-27.
6. Coleman, R.M.; Lombard, M.F.; Sicard, R.E. Fundamental Immunology. Wm.C Publishers, Dubuque. 1992.
7. Vickers, A. Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 2002; 20, 1069-1079.
8. Wollschlaeger, B.A. Herbal medicine. N. Engl. J. Med. 2003, 348, 1498-1501.
9. Kuttan, G.; Kuttan, R. Immunomodulatory activity of a peptide isolated from Viscum album extract. Immunol. Invest. 1992, 21, 285-296.
10. Mathew, S.; Kuttan, G. Immunomodulatory and antitumor activities of Tinospora cordifolia. Fitoterapia 1999, 70, 35-43.
11. Davis, L.; Kuttan, G. Immunomodulatory activity of Withania somnifera. J. Ethnopharmacol. 2000, 71, 193-202.
12. Jirovetz, L.; Buchbauer, G.; Wobus, A.; Shafi, M.P.; Jose, B. Medicinal used plants from India: Analysis of the essential oil of air-dried Biophytum sensitivum (L.) DC. Sci. Pharm. 2004, 72, 87-96.
13. Inngjerdingen, K.T.; Colibaly, A.; Diallo, D.; Michaelsen, T.E.; Paulsen, B.S. A complement fixing polysaccharide from Biophytum petersianum Klotzch, a medicinal plant from Mali, West Africa. Biomacromolecules 2006, 7, 48-53.
14. Guruvayoorappan, C.; Afira, A.H.; Kuttan, G. Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J. Basic Clin. Physiol. Pharmacol. 2006, 17(4), 255-267.
15. Guruvayoorappan, C.; Kuttan, G. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation. J. Exp. Ther. Oncol. 2007, 6, 241-250.
16. Guruvayoorappan, C.; Kuttan, G. Immunomodulatory and antitumor activity of Biophytum sensitivum extract. Asian Pacific J. Cancer Prev. 2007, 8, 27-32.
17. Lin, Y.L.; Wang, W.Y. Chemical constituents of Biophytum sensitivum. Chin. Pharm. 2003, 55, 71-75.
18. Kim, H.K.; Son, K.H.; Chang, H.W.; Kang, S.S.; Kim, H.P. Amentoflavone, a plant biflavone: a new potential anti-inflammatory agent. Arch. Pharm. Res. 1998, 21, 406-410.
19. Guruvayoorappan, C; Kuttan, G. Effect of amentoflavone on the inhibition of pulmonary metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Integr. Cancer Ther. 2007, 6, 185-197.
20. Wang, H.K.; Xla, Y.; Yang, Z.Y.; Natschke, S.; Lee, K. H. Recent advances in the discovery and development of flavonoids and their analogues as antitumors and anti-HIV agents. Adv. Exp. Med. Biol. 1998, 439, 191-225.
21. Ruiz de Morales, J.; Velez, D.; Subiza JL. Ehrlich tumor stimulates extramedullar hematopoiesis in mice without secreting identifiable colony-stimulating factors and without engagement of host T cells. Exp. Hematol. 1999, 27, 1757-1767.
22. Gupta, S.K.; Bhattacharya, B. Cytotoxicity assays. In A Handbook of Practical Immunology; Talwar, G.P. Ed.; Vikas Publishing House. New Delhi. 1983, 328-336.
23. Ziauddin, M.; Phansalkar, N.; Patki, P.; Diwanay, S.; Patwardhan, B. Studies on the immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 1996, 50: 69-76.
24. Fidler, I.J.; Poste, G. Immunomodulation of macrophages for cancer and antiviral therapy. Insite specific drug delivery. In: Tomlinson, I., Davis, S.S., Eds.; Wiley: New York. 1985; 111-135.
25. Urban, J.L.; Schreiber, H. Host-tumor interactions in immunosurveillance against cancer. Progr. Exp. Tumor Res. 1988, 32, 17-68.
26. Barlozzari, T.; Leonhardt, J.; Wiltrout, R.H.; Herberman, R.B.; Reynolds, C.W. Direct evidence for the role of LGL in the reduction of experimental tumor metastasis. J. Immunol. 1985, 134, 2783-2789.
27. Andreesen, R.; Scheibenbogen, C.; Brugger, W.; Krause, S.; Meerpohl, H.G.; Lesser, H.G. et al., Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res. 1990, 50, 7450-7456.
28. Wodner-Filipowicz, A.; Kalberer, C.P. Functions of natural killer cells in immune defense against human leukemia. Swiss Med. Wkly. 2006, 136, 359-364.
29. Harris, M. Monoclonal antibodies as therapeutic agents of cancer. Lancet Oncol. 2004, 5, 292-302.
30. Goldsby, R.A.; Kindt, T.J.; Osborne, B.A.; Kuby, J. Immunology. 5th Ed. New York. NY: W.H. Freeman; 2002.
31. Miller, J.S. Biology of natural killer cells in cancer and infection. Cancer Invest. 2002, 20, 1-14.